IL101241A
(en)
*
|
1992-03-16 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
|
DE4244122C1
(de)
*
|
1992-12-24 |
1994-06-01 |
Sanol Arznei Schwarz Gmbh |
Lyophilisierte, wirkstoffhaltige Emulsion zur intravenösen Applikation
|
CA2160681A1
(en)
*
|
1993-04-19 |
1994-10-27 |
Masao Takahashi |
Microemulsion preparation containing a slightly absorbable substance
|
ES2070076B1
(es)
*
|
1993-04-20 |
1996-04-16 |
Cusi Lab |
Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.
|
US5576016A
(en)
*
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
US20020099067A1
(en)
*
|
1993-07-08 |
2002-07-25 |
Ulrich Posanski |
Pharmaceutical compositions for sparingly soluble therapeutic agents
|
IL106578A
(en)
*
|
1993-08-03 |
2000-08-13 |
Yissum Res Dev Co |
Pharmaceutical compositions for drug targeting
|
FR2709666B1
(fr)
*
|
1993-09-07 |
1995-10-13 |
Oreal |
Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
|
US5961970A
(en)
*
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
US5672358A
(en)
*
|
1994-06-21 |
1997-09-30 |
Ascent Pharmaceuticals, Inc. |
Controlled release aqueous emulsion
|
JPH0827018A
(ja)
*
|
1994-07-22 |
1996-01-30 |
Sanwa Kagaku Kenkyusho Co Ltd |
生理活性ペプチド又は蛋白質を含有する薬剤組成物
|
KR19990045763A
(ko)
*
|
1995-09-18 |
1999-06-25 |
유나이티드 스테이트 아미 메디칼 리서치 머티어리얼커맨드 (유에스에이엠알엠씨) |
비공유결합성으로 착염화된 다가의 프로테오좀 서브-유니트 백신의 개선된 제조 방법
|
JPH11513698A
(ja)
*
|
1995-10-25 |
1999-11-24 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
神経保護物質およびパーフルオロケミカルの注射剤
|
US5980945A
(en)
*
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
ES2118033B1
(es)
*
|
1996-02-16 |
1999-07-01 |
Bial Ind Farmaceutica S A |
Formulacion farmaceutica antiinflamatoria.
|
SE9602280D0
(sv)
*
|
1996-06-10 |
1996-06-10 |
Pharmatrix Ab |
Immunstimulerande lipidformulering
|
AU727447B2
(en)
*
|
1996-07-03 |
2000-12-14 |
University Of Pittsburgh |
Emulsion formulations for hydrophilic active agents
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
AU719085B2
(en)
*
|
1996-08-22 |
2000-05-04 |
Rtp Pharma Corporation |
Processes of preparing or stabilising microparticles
|
SE9603667D0
(sv)
*
|
1996-10-08 |
1996-10-08 |
Astra Ab |
Pharmaceutical compositions
|
US6071904A
(en)
*
|
1996-12-11 |
2000-06-06 |
Alcon Laboratories, Inc. |
Process for manufacturing ophthalmic suspensions
|
US7060277B2
(en)
*
|
1996-12-30 |
2006-06-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins
|
US6537561B1
(en)
*
|
1997-02-27 |
2003-03-25 |
Nippon Shinyaku Co., Ltd. |
Fat emulsion for oral administration
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US5980912A
(en)
*
|
1997-03-25 |
1999-11-09 |
Zonagen, Inc. |
Chitosan induced immunopotentiation
|
SE9702776D0
(sv)
*
|
1997-07-22 |
1997-07-22 |
Pharmacia & Upjohn Ab |
Method of preparing pharmaceutical compositions
|
US6306433B1
(en)
|
1997-08-12 |
2001-10-23 |
Pharmacia Ab |
Method of preparing pharmaceutical compositions
|
IL122084A
(en)
*
|
1997-10-31 |
1999-09-22 |
Lurident Ltd |
Formulation for personal care with mucoadhesive properties
|
US6270464B1
(en)
|
1998-06-22 |
2001-08-07 |
Artemis Medical, Inc. |
Biopsy localization method and device
|
GB9726916D0
(en)
*
|
1997-12-19 |
1998-02-18 |
Danbiosyst Uk |
Nasal formulation
|
US6221378B1
(en)
|
1998-02-10 |
2001-04-24 |
Generex Pharmaceuticals Incorporated |
Mixed micellar delivery system and method of preparation
|
US6017545A
(en)
*
|
1998-02-10 |
2000-01-25 |
Modi; Pankaj |
Mixed micellar delivery system and method of preparation
|
US7070799B1
(en)
*
|
1998-02-10 |
2006-07-04 |
Generex Pharmaceuticals, Inc. |
Method for administering insulin to the buccal region
|
ES2232114T3
(es)
|
1998-03-09 |
2005-05-16 |
Takeda Pharmaceutical Company Limited |
Derivados de cicloalqueno, procedimiento para su produccion, y uso.
|
DE19819273A1
(de)
*
|
1998-04-30 |
1999-11-11 |
Pharmatec International S Giul |
Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
|
DK1075276T3
(da)
*
|
1998-05-07 |
2008-02-11 |
Corixa Corp |
Adjuvanssammensætning og fremgangsmåder til dens anvendelse
|
TWI241915B
(en)
|
1998-05-11 |
2005-10-21 |
Ciba Sc Holding Ag |
A method of preparing a pharmaceutical end formulation using a nanodispersion
|
ES2216517T3
(es)
|
1998-05-29 |
2004-10-16 |
Skyepharma Canada Inc. |
Composiciones de microcapsulas termoprotegidas y procedimiento para su esterilizacion terminal con vapor.
|
AU5207799A
(en)
*
|
1998-07-02 |
2000-01-24 |
Genzyme Corporation |
Transgene expression in polarized cells
|
DE19830375A1
(de)
*
|
1998-07-08 |
2000-01-13 |
K D Pharma Bexbach Gmbh |
Mikroverkapselte ungesättigte Fettsäure oder Fettsäureverbindung oder Mischung aus Fettsäuren und/oder Fettsäureverbindungen
|
DE69929128T2
(de)
*
|
1998-08-31 |
2006-06-29 |
Nipro Corp. |
Nährstoffinfusionspräparat
|
JP2007262088A
(ja)
*
|
1998-08-31 |
2007-10-11 |
Nipro Corp |
栄養輸液製剤
|
AU6333499A
(en)
*
|
1998-10-14 |
2000-05-01 |
Cognis Deutschland Gmbh |
Use of nanoscale sterols and sterol esters
|
EP1133281A1
(de)
|
1998-11-20 |
2001-09-19 |
RTP Pharma Inc. |
Dispergierbare mit phospholipid stabilisierte mikropartikel
|
FR2787326B1
(fr)
*
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
WO2000040219A1
(en)
|
1998-12-30 |
2000-07-13 |
Dexcel Ltd. |
Dispersible concentrate for the delivery of cyclosporin
|
US7655252B2
(en)
*
|
1999-04-28 |
2010-02-02 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
US8232320B2
(en)
*
|
1999-04-28 |
2012-07-31 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
US7767216B2
(en)
|
1999-04-28 |
2010-08-03 |
The Regents Of The University Of Michigan |
Antimicrobial compositions and methods of use
|
EP1176949B1
(de)
*
|
1999-05-07 |
2014-12-10 |
PharmaSol GmbH |
Lipidpartikel auf der basis von mischungen von flüssigen und festen lipiden und verfahren zu ihrer herstellung
|
AU763945B2
(en)
*
|
1999-06-04 |
2003-08-07 |
Skyepharma Inc. |
Oil-core compositions for the sustained release of hydrophobic drugs
|
US6541025B1
(en)
|
1999-12-30 |
2003-04-01 |
Shear/Kershman Laboratories, Inc. |
Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
|
US7919113B2
(en)
*
|
1999-12-30 |
2011-04-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dispersible concentrate lipospheres for delivery of active agents
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
US6514523B1
(en)
|
2000-02-14 |
2003-02-04 |
Ottawa Heart Institute Research Corporation |
Carrier particles for drug delivery and process for preparation
|
AU3847801A
(en)
*
|
2000-02-15 |
2001-08-27 |
Intellivax International Inc |
Proteosome influenza vaccine
|
FR2805761B1
(fr)
*
|
2000-03-02 |
2002-08-30 |
Mainelab |
Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
|
AU2001245552A1
(en)
*
|
2000-03-09 |
2001-09-17 |
Emory University |
Transcutaneous immunization for large particulate antigens
|
US6861060B1
(en)
|
2000-04-21 |
2005-03-01 |
Elena Luriya |
Personal care formulations
|
DE10027948A1
(de)
*
|
2000-06-08 |
2001-12-20 |
Henkel Kgaa |
Verfahren zur Herstellung von Nanopartikel-Suspensionen
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
DE10036871A1
(de)
*
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
JP2006512401A
(ja)
*
|
2001-06-05 |
2006-04-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
ナノエマルジョンワクチン
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
CA2454920C
(en)
*
|
2001-07-26 |
2013-06-25 |
Otago Innovation Limited |
Antigenic compositions
|
EP1420783A4
(de)
*
|
2001-08-03 |
2009-09-30 |
Takeda Pharmaceutical |
Stabile emulsionszusammensetzung
|
US7125568B2
(en)
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
EP1429749A2
(de)
|
2001-09-26 |
2004-06-23 |
Baxter International Inc. |
Herstellung von nanopartikeln im submikrometerbereich durch dispersion und entzug des lösungsmittels oder der flüssigen phase
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
IL145926A0
(en)
|
2001-10-15 |
2002-07-25 |
Mor Research Applic Ltd |
Peptide epitopes of mimotopes useful in immunomodulation
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
WO2003057128A2
(en)
*
|
2001-12-11 |
2003-07-17 |
Dor Biopharma, Inc. |
Lipid particles and suspensions and uses thereof
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
JP4549625B2
(ja)
*
|
2002-01-05 |
2010-09-22 |
株式會社アモーレパシフィック |
人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物
|
KR20030065831A
(ko)
*
|
2002-02-01 |
2003-08-09 |
주식회사 태평양 |
사이클로스포린을 함유한 지속 방출형 약학적 조성물
|
US6899890B2
(en)
*
|
2002-03-20 |
2005-05-31 |
Kv Pharmaceutical Company |
Bioadhesive drug delivery system
|
US6824763B2
(en)
|
2002-05-30 |
2004-11-30 |
Kimberly-Clark Worldwide, Inc. |
Anti-fungal powder having enhanced excipient properties
|
US8435942B2
(en)
*
|
2002-05-31 |
2013-05-07 |
Transdermal Biotechnology, Inc. |
Methods for formulating stabilized insulin compositions
|
US20040018237A1
(en)
|
2002-05-31 |
2004-01-29 |
Perricone Nicholas V. |
Topical drug delivery using phosphatidylcholine
|
HUP0202032A2
(hu)
*
|
2002-06-19 |
2004-10-28 |
D. Endre Radics |
Nanoemulziós formulációban található bioaktív anyagok emberi szervezetbe való bevitele a szájüreg nyálkahártyáján keresztül, mechanikus pumpájú spray által.
|
US20040106785A1
(en)
*
|
2002-07-25 |
2004-06-03 |
Micrologix Biotech Inc. |
Inhibitors of RNA dependent RNA polymerase and uses thereof
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
JP5030383B2
(ja)
*
|
2002-10-21 |
2012-09-19 |
アルヴィヴォ インコーポレイテッド |
生物活性化合物を含む表面コーティング
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
KR101108439B1
(ko)
|
2002-10-25 |
2012-01-31 |
포믹스 리미티드 |
화장료 및 약제용 거품제
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
ITMI20022323A1
(it)
*
|
2002-10-31 |
2004-05-01 |
Maria Rosa Gasco |
Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
|
US7255867B2
(en)
*
|
2002-11-15 |
2007-08-14 |
Id Biomedical Corporation Of Quebec |
Vaccine
|
WO2004073684A2
(en)
*
|
2003-02-14 |
2004-09-02 |
Children's Hospital & Research Center At Oakland |
Lipophilic drug delivery vehicle and methods of use thereof
|
WO2004084859A2
(en)
*
|
2003-03-21 |
2004-10-07 |
Nastech Pharmaceutical Company Inc. |
Nasal calcitonin formulations containing chlorobutanol
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
US20050208083A1
(en)
*
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
US7368537B2
(en)
*
|
2003-07-15 |
2008-05-06 |
Id Biomedical Corporation Of Quebec |
Subunit vaccine against respiratory syncytial virus infection
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
US20050152919A1
(en)
*
|
2003-09-15 |
2005-07-14 |
Id Biomedical Corporation Of Quebec |
Measles subunit vaccine
|
WO2005030172A1
(en)
*
|
2003-09-24 |
2005-04-07 |
The Regents Of The University And Methods |
Antimicrobial nanoemulsion compositions and methods
|
AU2004285553B2
(en)
*
|
2003-10-31 |
2009-12-10 |
Teva Pharmaceutical Industries, Ltd. |
Nanoparticles for drug delivery
|
EP1711163A2
(de)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Unter verwendung von selbststabilisierenden mitteln hergestellte dispersionen
|
ES2387619T3
(es)
*
|
2004-04-19 |
2012-09-27 |
Centre National De La Recherche Scientifique (Cnrs) |
Suplementos de tensioactivos pulmonares
|
ITMI20041151A1
(it)
*
|
2004-06-09 |
2004-09-09 |
Maria Rosa Gasco |
Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
|
US7348802B2
(en)
*
|
2004-06-15 |
2008-03-25 |
Stmicroelectronics Pvt. Ltd. |
Differential receiver
|
KR101347105B1
(ko)
*
|
2004-06-25 |
2014-01-02 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
신경계 장애의 예방을 위한 조성물 및 방법
|
KR20070052273A
(ko)
*
|
2004-06-30 |
2007-05-21 |
아이디 바이오메디컬 코포레이션 오브 퀘벡 |
코로나바이러스 감염의 치료를 위한 백신 조성물
|
US7871632B2
(en)
|
2004-07-12 |
2011-01-18 |
Adventrx Pharmaceuticals, Inc. |
Compositions for delivering highly water soluble drugs
|
US20060057216A1
(en)
*
|
2004-09-15 |
2006-03-16 |
Salamone Joseph C |
Low-obscuration image transmitting particulate ocular therapeutic formulations
|
EP1674085A1
(de)
*
|
2004-12-22 |
2006-06-28 |
Universite Libre De Bruxelles |
Feste Lipidteilchen als pharmazeutische annehmbare Füllstoffe oder Träger zur Inhalation
|
EP1861067A2
(de)
*
|
2005-03-09 |
2007-12-05 |
Combe Incorporated |
Stabile mischemulsionen mit halbfesten dispersionen aus mindestens zwei separaten und eindeutig unterschiedlichen partikelgrössenbereichen
|
FR2885538B1
(fr)
*
|
2005-05-16 |
2007-08-10 |
Univ Claude Bernard Lyon |
Nouveau procede de preparation de particules lipidiques solides, mettant en oeuvre un reacteur membranaire
|
FR2887457B1
(fr)
*
|
2005-06-23 |
2007-10-05 |
Fond Bettencourt Schueller |
Vaccination par ciblage transcutane
|
KR20130079645A
(ko)
*
|
2005-07-18 |
2013-07-10 |
유니버시티 오브 메사츄세츠 로웰 |
나노에멀젼 조성물 및 이의 제조 및 사용 방법
|
EP1926466A2
(de)
*
|
2005-09-19 |
2008-06-04 |
Combe Incorporated |
Stabile emulsionssysteme mit hoher salzverträglichkeit
|
JP5362360B2
(ja)
*
|
2005-10-11 |
2013-12-11 |
イッサム リサーチ ディヴェロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
経鼻投与用組成物
|
US7638142B2
(en)
*
|
2005-10-12 |
2009-12-29 |
Vitamin Science, Inc. |
Therapeutic composition for the treatment of dry eye syndrome
|
WO2007054323A1
(de)
*
|
2005-11-10 |
2007-05-18 |
Vortex-Nanofluid Gmbh |
Vorrichtung mit sprühvorrichtung und verfahren zum herstellen von nanodispersionen
|
EP3144013B1
(de)
|
2005-12-01 |
2018-11-14 |
University Of Massachusetts Lowell |
Botulin-nanoemulsionen
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
KR100792557B1
(ko)
*
|
2006-04-05 |
2008-01-09 |
한남대학교 산학협력단 |
나노 캡슐화를 이용하여 제조된 지질 핵 및 고분자 쉘구조를 갖는 단백질 약물 전달용 나노 미립구
|
US9839685B2
(en)
*
|
2006-04-13 |
2017-12-12 |
The Regents Of The University Of Michigan |
Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
|
US10138279B2
(en)
|
2006-04-13 |
2018-11-27 |
Regents Of The University Of Michigan |
Compositions and methods for Bacillus anthracis vaccination
|
US20080038295A1
(en)
*
|
2006-04-13 |
2008-02-14 |
Regents Of The University Of Michigan |
Compositions and methods for orthopox virus vaccination
|
US20070243137A1
(en)
*
|
2006-04-18 |
2007-10-18 |
Nanoprobes, Inc. |
Cell and sub-cell methods for imaging and therapy
|
AU2007295178B2
(en)
*
|
2006-09-15 |
2013-04-18 |
Echo Pharmaceuticals B.V. |
Granulate containing a pharmaceutically active substance and anemulsifier and method for its manufacture
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
CA2671447A1
(en)
|
2006-12-01 |
2008-06-12 |
Anterios, Inc. |
Amphiphilic entity nanoparticles
|
CN107080703A
(zh)
|
2006-12-01 |
2017-08-22 |
安特里奥公司 |
肽纳米粒子和其用途
|
CA2677455A1
(en)
*
|
2007-02-07 |
2008-08-14 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Recombinant antigens of human cytomegalovirus (hcmv)
|
AU2008222822A1
(en)
*
|
2007-03-05 |
2008-09-12 |
Washington University |
Nanoparticle delivery systems for membrane-integrating peptides
|
US11246831B2
(en)
|
2007-03-30 |
2022-02-15 |
Particle Sciences, Inc. |
Particle formulations and uses thereof
|
EP2152304B1
(de)
|
2007-05-02 |
2018-08-22 |
The Regents of the University of Michigan |
Therapeutische zusammensetzungen in nanoemulsionsform und anwendungsverfahren dafür
|
US8309129B2
(en)
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
WO2008135855A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
US20080292663A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
CA2688415C
(en)
|
2007-05-31 |
2015-11-10 |
Anterios, Inc. |
Nucleic acid nanoparticles and uses therefor
|
WO2008149192A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
WO2009042114A2
(en)
|
2007-09-21 |
2009-04-02 |
The Johns Hopkins University |
Phenazine derivatives and uses thereof
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
WO2009073216A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
|
EP2231169B1
(de)
|
2007-12-06 |
2016-05-04 |
Bend Research, Inc. |
Pharmazeutische zusammensetzungen mit nanopartikeln und resuspensionsmaterial
|
US8518376B2
(en)
|
2007-12-07 |
2013-08-27 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
US8063020B2
(en)
*
|
2007-12-22 |
2011-11-22 |
Simpkins Cuthbert O |
Resuscitation fluid
|
US8906855B2
(en)
|
2007-12-22 |
2014-12-09 |
Vivacelle Bio, Inc. |
Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
|
US8618056B2
(en)
|
2007-12-22 |
2013-12-31 |
Cuthbert O. Simpkins |
Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
|
EP2242476A2
(de)
|
2008-01-14 |
2010-10-27 |
Foamix Ltd. |
Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
|
WO2009143174A2
(en)
*
|
2008-05-19 |
2009-11-26 |
Children's Medical Center Corporation |
Chemical permeation enhancers enhance nerve blockade by toxins
|
US8609733B2
(en)
*
|
2008-05-19 |
2013-12-17 |
Massachusetts Institute Of Technology |
Sensory-specific local anesthesia and prolonged duration local anesthesia
|
CA2725329C
(en)
*
|
2008-05-23 |
2013-10-01 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
WO2009158678A1
(en)
|
2008-06-27 |
2009-12-30 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use therefor
|
DE102008045152A1
(de)
*
|
2008-07-09 |
2010-01-14 |
Universität Duisburg-Essen |
Künstliche Sauerstoffträger und ihre Verwendung
|
CA2730760A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
US20100092526A1
(en)
|
2008-09-26 |
2010-04-15 |
Nanobio Corporation |
Nanoemulsion therapeutic compositions and methods of using the same
|
WO2010042499A1
(en)
*
|
2008-10-06 |
2010-04-15 |
Banner Pharmacaps, Inc. |
Stable solutions of orlistat for pharmaceutical dosage forms
|
EP2376089B1
(de)
|
2008-11-17 |
2018-03-14 |
The Regents of the University of Michigan |
Krebsvakzine-zusammensetzungen und anwendungsverfahren dafür
|
FR2939699B1
(fr)
|
2008-12-12 |
2011-05-06 |
Univ Angers |
Procede de preparation de nanoparticules lipidiques
|
WO2010087986A2
(en)
*
|
2009-01-30 |
2010-08-05 |
Simpkins Cuthbert O |
Resuscitation fluid
|
US8952152B2
(en)
|
2009-03-24 |
2015-02-10 |
Proteus S.A. |
Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
|
CN102395548A
(zh)
*
|
2009-04-15 |
2012-03-28 |
奥斯金生医公司 |
全氟化碳类乳液
|
CA2760186C
(en)
|
2009-04-28 |
2019-10-29 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
WO2010132833A1
(en)
*
|
2009-05-14 |
2010-11-18 |
The Regents Of The University Of Michigan |
Streptococcus vaccine compositions and methods of using the same
|
CN101579291B
(zh)
*
|
2009-05-20 |
2011-06-15 |
清华大学 |
一种白藜芦醇磷脂复合物纳米乳液及其制备方法与应用
|
EP3020412B1
(de)
*
|
2009-06-16 |
2017-10-11 |
The Regents of the University of Michigan |
Nanoemulsionsimpfstoffe
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
WO2011013008A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
WO2011017520A1
(en)
|
2009-08-05 |
2011-02-10 |
Wake Forest University Health Sciences |
Compositions and methods for inducing apoptosis in prostate cancer cells
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
MX359879B
(es)
|
2009-10-02 |
2018-10-12 |
Foamix Pharmaceuticals Ltd |
Composiciones tópicas de tetraciclina.
|
US8174881B2
(en)
|
2009-11-24 |
2012-05-08 |
Micron Technology, Inc. |
Techniques for reducing disturbance in a semiconductor device
|
CN102933200B
(zh)
*
|
2009-12-18 |
2015-11-25 |
莱迪杜德制药公司 |
包含磷脂的单相凝胶组合物
|
FR2956320B1
(fr)
*
|
2010-02-17 |
2013-12-20 |
Commissariat Energie Atomique |
Nanoemulsion pour la delivrance d'au moins deux agents d'interet
|
US20110229516A1
(en)
*
|
2010-03-18 |
2011-09-22 |
The Clorox Company |
Adjuvant phase inversion concentrated nanoemulsion compositions
|
CA2792136C
(en)
*
|
2010-03-24 |
2020-08-04 |
Medesis Pharma |
Reverse micelle system comprising metal ions and use thereof
|
EP3187585A1
(de)
|
2010-03-25 |
2017-07-05 |
Oregon Health&Science University |
Cmv-glycoproteine und rekombinante vektoren
|
TWI540319B
(zh)
|
2010-03-29 |
2016-07-01 |
中央研究院 |
以細胞質譜分析定量細胞所攝入之奈米/微米粒子
|
CN102232932B
(zh)
*
|
2010-04-27 |
2013-06-05 |
重庆莱美药业股份有限公司 |
果胶-阿霉素轭合物的冻干制剂及制备方法
|
US10758630B2
(en)
|
2010-08-13 |
2020-09-01 |
The Johns Hopkins University |
Topical compositions and methods of detection and treatment
|
US8658676B2
(en)
*
|
2010-10-12 |
2014-02-25 |
The Medicines Company |
Clevidipine emulsion formulations containing antimicrobial agents
|
US20140046181A1
(en)
*
|
2011-01-05 |
2014-02-13 |
The Regents Of The University Of California |
Acoustically responsive particles with decreased cavitation threshold
|
WO2012125214A1
(en)
|
2011-03-17 |
2012-09-20 |
Transdermal Biotechnology, Inc. |
Topical nitric oxide systems and methods of use thereof
|
SI2691530T1
(en)
|
2011-06-10 |
2018-08-31 |
Oregon Health & Science University |
CMV glycoproteins and recombinant vectors
|
KR20140057414A
(ko)
*
|
2011-06-22 |
2014-05-12 |
바이옴 바이오사이언스 피브이티. 엘티디. |
컨쥬게이트계 항진균 및 항세균 프로드러그
|
US20130189754A1
(en)
|
2011-09-12 |
2013-07-25 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
|
KR101803902B1
(ko)
*
|
2011-09-16 |
2017-12-04 |
(주)아모레퍼시픽 |
세라마이드를 포함하는 피부 외용제 조성물
|
JP2014526519A
(ja)
*
|
2011-09-16 |
2014-10-06 |
ナノケア テクノロジーズ,インコーポレイティド |
ジャスモネート化合物の組成物および使用方法
|
EP2586461A1
(de)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Von einem eingehüllten Virus abgeleitete Virenpartikel
|
WO2013082503A1
(en)
*
|
2011-12-01 |
2013-06-06 |
Flow Pharma, Inc. |
Peptide particle formulation
|
WO2013138334A1
(en)
|
2012-03-12 |
2013-09-19 |
Advanced Bioadjuvants, Llc |
Adjuvant and vaccine compositions
|
TWI483747B
(zh)
*
|
2012-05-29 |
2015-05-11 |
Univ Nat Chiao Tung |
口服式藥物載體及其製備方法
|
ES2631608T3
(es)
|
2012-06-27 |
2017-09-01 |
International Aids Vaccine Initiative |
Variante de la glicoproteína Env del VIH-1
|
US8871258B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment and prevention of learning and memory disorders
|
US8871257B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
|
US8871260B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and compositions for muscular and neuromuscular diseases
|
US8871261B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Cancer treatments and compositions for use thereof
|
US8871256B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and systems for treatment of inflammatory diseases with nitric oxide
|
US8871262B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Compositions and methods for treatment of osteoporosis and other indications
|
US8871259B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Techniques and systems for treatment of neuropathic pain and other indications
|
US8871255B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment of skin and soft tissue infection with nitric oxide
|
US8871254B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
|
US20140234433A1
(en)
*
|
2013-02-15 |
2014-08-21 |
Nicholas V. Perricone |
Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin
|
EP2958551B1
(de)
|
2013-02-25 |
2020-08-05 |
Particle Sciences, Inc. |
Partikelformulierungen zur abgabe von tlr-agonisten und antigenen
|
US9687520B2
(en)
|
2013-03-13 |
2017-06-27 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US9314417B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
US9393265B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9339457B2
(en)
|
2013-03-13 |
2016-05-17 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9314433B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9314422B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US20140271937A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9314423B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Hair treatment systems and methods using peptides and other compositions
|
US9295637B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Compositions and methods for affecting mood states
|
US20140271731A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9320706B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9320758B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9295647B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US9393264B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9750787B2
(en)
|
2013-03-13 |
2017-09-05 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US9241899B2
(en)
|
2013-03-13 |
2016-01-26 |
Transdermal Biotechnology, Inc. |
Topical systems and methods for treating sexual dysfunction
|
US9849160B2
(en)
|
2013-03-13 |
2017-12-26 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US20140271938A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US9387159B2
(en)
|
2013-03-13 |
2016-07-12 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
US9295636B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9724419B2
(en)
|
2013-03-13 |
2017-08-08 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
PL2968225T3
(pl)
|
2013-03-15 |
2019-08-30 |
The Children's Medical Center Corporation |
Preparaty skojarzone neosaksytoksyny do przedłużonego znieczulenia miejscowego
|
FR3008900B1
(fr)
*
|
2013-07-25 |
2018-03-30 |
Centre Nat Rech Scient |
Nanoparticules lipidiques multicompartimentees
|
EP2848937A1
(de)
|
2013-09-05 |
2015-03-18 |
International Aids Vaccine Initiative |
Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
|
US10058604B2
(en)
|
2013-10-07 |
2018-08-28 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
WO2015057751A1
(en)
|
2013-10-14 |
2015-04-23 |
Nanosphere Health Sciences, Llc |
Nanoparticle compositions and methods as carriers of nutraceutical factors across cell membranes and biological barriers
|
LT3060041T
(lt)
|
2013-10-25 |
2021-03-25 |
Insmed Incorporated |
Prostaciklino junginiai
|
IL246456B1
(en)
*
|
2013-12-31 |
2024-02-01 |
Access To Advanced Health Inst |
Formulations will be assembled into a single vial
|
US9895311B2
(en)
*
|
2014-09-25 |
2018-02-20 |
Pharmiva Ab |
Foam-forming compositions and methods for delivering an active to a body cavity
|
US10343979B2
(en)
|
2014-11-18 |
2019-07-09 |
Insmed Incorporated |
Methods of manufacturing treprostinil and treprostinil derivative prodrugs
|
US20160151285A1
(en)
*
|
2014-11-28 |
2016-06-02 |
University Of Malaya |
Method to produce slow release delivery carrier lipid nanoparticles of different log p value
|
CA2970917C
(en)
|
2014-12-15 |
2019-09-17 |
Nanosphere Health Sciences, Llc |
Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of nsaids
|
BR112017014229A2
(pt)
|
2014-12-31 |
2018-03-06 |
Nanocare Technologies, Inc. |
conjugado, composição, e, método para tratamento de um distúrbio.
|
CA2974208A1
(en)
*
|
2015-01-21 |
2017-04-06 |
Michael WILLINSKY |
Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaler
|
CA2979184C
(en)
*
|
2015-03-10 |
2020-09-08 |
Nanosphere Health Sciences, Llc |
Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms
|
US10174292B2
(en)
|
2015-03-20 |
2019-01-08 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
US9931394B2
(en)
|
2015-03-23 |
2018-04-03 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
US20160346221A1
(en)
|
2015-06-01 |
2016-12-01 |
Autotelic Llc |
Phospholipid-coated therapeutic agent nanoparticles and related methods
|
JP2018530585A
(ja)
*
|
2015-10-16 |
2018-10-18 |
マリナス ファーマシューティカルズ インコーポレイテッド |
ナノ粒子を含む注射可能な神経ステロイド製剤
|
CN110381929A
(zh)
*
|
2016-06-13 |
2019-10-25 |
阿森迪亚制药有限责任公司 |
卡维地洛分散系统的肠胃外缓释传递
|
US10398641B2
(en)
|
2016-09-08 |
2019-09-03 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
WO2018093465A1
(en)
|
2016-11-21 |
2018-05-24 |
Eirion Therapeutics, Inc. |
Transdermal delivery of large agents
|
MX2019009642A
(es)
*
|
2017-02-15 |
2019-11-11 |
Molecular Infusions Llc |
Formulaciones.
|
EP3628002B1
(de)
|
2017-05-23 |
2023-03-22 |
Pharmiva AB |
Schaumbildende zusammensetzungen zur abgabe eines wirkstoffs in eine körperhöhle
|
TWI719263B
(zh)
*
|
2017-10-27 |
2021-02-21 |
財團法人國家衛生研究院 |
用於鼻黏膜之奈米級乳液免疫載劑及其製備方法
|
KR102052912B1
(ko)
*
|
2018-03-30 |
2019-12-06 |
중앙대학교 산학협력단 |
산소를 함유하는 나노 버블의 제조 방법, 나노 버블 및 이를 포함하는 약물 전달체
|
WO2020016658A2
(en)
|
2018-07-18 |
2020-01-23 |
Glatt Gmbh |
Immediate release formulations of cannabinoids
|
KR20210114409A
(ko)
*
|
2018-12-11 |
2021-09-23 |
디스럽션 랩스 인코퍼레이티드 |
치료제 전달용 조성물과 이의 이용 및 제조 방법
|
EP3937912A4
(de)
*
|
2019-03-13 |
2022-12-21 |
Ulagaraj Selvaraj |
Stabilisierte feste nanopartikelformulierungen von cannabinoiden und cannabinoid-analogen mit reduzierter ostwald-reifung zur oralen, inhalativen, nasalen und parenteralen wirkstoffabgabe
|
TR201905678A2
(tr)
*
|
2019-04-16 |
2020-11-23 |
Istanbul Medipol Ueniversitesi |
Kurkumi̇n ve pi̇peri̇n doğal bi̇leşenleri̇ni̇ i̇hti̇va eden kati li̇pi̇t emulsi̇yonlarinin tedavi̇ amaçli uygulamalari
|
WO2020223237A1
(en)
|
2019-04-29 |
2020-11-05 |
Insmed Incorporated |
Dry powder compositions of treprostinil prodrugs and methods of use thereof
|
US20200352191A1
(en)
*
|
2019-05-06 |
2020-11-12 |
Karl Lonsbery |
Edible formulations and uses thereof
|
EP4084658A4
(de)
*
|
2020-01-02 |
2024-01-17 |
Spoke Sciences Inc |
Systeme und verfahren zur erzeugung homogener mischungen aus gebrühten getränken und wirkstoffen
|
WO2022026796A1
(en)
*
|
2020-07-31 |
2022-02-03 |
Altaire Pharmaceuticals, Inc. |
Ophthalmic compositions for delivering meibum-like materials
|
US11058637B1
(en)
*
|
2020-11-25 |
2021-07-13 |
King Abdulaziz University |
Surface-modified emulsomes for intranasal delivery of drugs
|
WO2023108513A1
(zh)
*
|
2021-12-16 |
2023-06-22 |
威海天原生物科技有限公司 |
植物油制剂及其制备方法
|